Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches

Francois Grand'Maison; Michael Yeung; Sarah A. Morrow; Liesly Lee; Francois Emond; Brian J. Ward; Pierre Laneuville; Robyn Schecter

doi:10.4103/1673-5374.239432

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches

DOI: 10.4103/1673-5374.239432

Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches

Francois Grand'Maison

Michael Yeung

Sarah A. Morrow

Liesly Lee

Francois Emond

Brian J. Ward

Pierre Laneuville

Robyn Schecter

Keywords：relapsing multiple sclerosishigh efficacy disease-modifying therapiestreatment optimizationtreatment sequencingtherapeutic inertiasub-optimal treatmentprogressive diseaseimmune effects

Publication Date：2018-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 1871-1874 )

Neural Regeneration Research

ISTICSCI

ISSN：1673-5374

Year, Vol.(Issue)：2018,13(11)